Treatment of osteoporosis with denosumab in patients with decreased kidney function
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Treatment of osteoporosis with denosumab in patients with decreased kidney function ; volume:18 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-4 ; date:12.2023
Archives of osteoporosis ; 18, Heft 1 (26.7.2023), 1-4, 12.2023
- Urheber
-
Svendsen, Ole Lander
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11657-023-01306-x
- URN
-
urn:nbn:de:101:1-2023102710430603887097
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Svendsen, Ole Lander
- SpringerLink (Online service)
Ähnliche Objekte (12)
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review